FLPIM
EW icon

F.L. Putnam Investment Management’s Edwards Lifesciences EW Stock Holding History

F.L. Putnam Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Buy
5,031
+761
+18% +$63.7K 0.01% 481
2026
Q1 		$342K Hold
4,270
– – 0.01% 489
2025
Q4 		$364K Sell
4,270
-35
-0.8% -$2.87K 0.01% 482
2025
Q3 		$335K Sell
4,305
-4,500
-51% -$352K 0.01% 488
2025
Q2 		$689K Buy
8,805
+7
+0.1% +$522 0.01% 356
2025
Q1 		$638K Sell
8,798
-1,198
-12% -$85.7K 0.01% 369
2024
Q4 		$740K Sell
9,996
-8,852
-47% -$620K 0.01% 356
2024
Q3 		$1.03M Sell
18,848
-264
-1% -$19.2K 0.02% 325
2024
Q2 		$1.77M Buy
19,112
+16,637
+672% +$1.47M 0.03% 255
2024
Q1 		$237K Buy
+2,475
New +$208K 0.01% 444

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

F.L. Putnam Investment Management's EW Position: Q2 2026 in Review

F.L. Putnam Investment Management increased its Edwards Lifesciences (EW) stake by 18% in Q2 2026, buying an estimated $63.7K and bringing the position to 5,031 shares worth $455K. The position accounts for 0.01% of the portfolio, ranked #481.

F.L. Putnam Investment Management first reported a position in EW in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.77M in Q2 2024. 834 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • F.L. Putnam Investment Management held 5,031 shares of Edwards Lifesciences worth $455K as of Q2 2026.
  • F.L. Putnam Investment Management bought 761 Edwards Lifesciences shares in Q2 2026, an estimated $63.7K.
  • Edwards Lifesciences made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #481 holding.
  • F.L. Putnam Investment Management first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
  • F.L. Putnam Investment Management's Edwards Lifesciences position peaked at $1.77M in Q2 2024.
  • 834 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.